Search
for
Sort by
Research 121–150 of 1000+
- Cross‐Sex Hormone Therapy in Trans Persons Is Safe and Effective at Short‐Time Follow‐Up: Results from the European Network for the Investigation of Gender Incongruence
- Cutaneous complications of chemotherapeutic agents
- Testosterone therapy for transgender men
- Non polycystic ovary syndrome–related endocrine disorders associated with hirsutism
- Advanced Medical Therapies in the Management of Non-Scarring Alopecia: Areata and Androgenic Alopecia
- Recommendations of endocrine treatment for patients with gender dysphoria
- Endocrine disorders and hormonal therapy for adolescent acne
- Interpretation of Laboratory Data and General Physical Examination by Pharmacists
- Abstracts
- Exploring the Lived Experiences and Coping Mechanisms of Unmarried Women with Polycystic Ovary Syndrome (PCOS) in Pakistan
- Updates on Hirsutism: A Narrative Review
- Debatable Topics in PCOS Patients
- Acne and acneiform eruptions
- Skin
- Climacteric Commentaries
- Evidence Synthesis Gone Awry: The Perils of Aggregating Ineffective or Unsafe Doses in Alopecia Areata Reviews
- Signal Mining for Non-Bleeding Adverse Event in Novel Oral Anticoagulants: A Pharmacovigilance Study Based on the FAERS Database
- Clinical and instrumental characterization of hair and scalp aging in nonbalding Caucasian women
- Poster Abstracts
- Lab Quality Management and Methodology
- Skin Disorders
- YouTube and the implementation and discontinuation of the oral contraceptive pill: A mixed-method content analysis
- The Use/Abuse of Oral Contraceptive Pills Among Males: A Mixed-Method Explanatory Sequential Study Over Jordanian Community Pharmacists
- The North American Menopause Society Recommendations for Clinical Care of Midlife Women
- Dermatoses of pregnancy
- Physiologic skin changes in pregnancy
- Hypersensitivity reactions to anticoagulant drugs: diagnosis and management options
- What Surgeons Need to Know About Gender Confirmation Surgery When Providing Care for Transgender Individuals
- COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology
- Anabolic-androgenic steroids and cardiovascular risk